Jeffery W. Kelly
for elucidating the molecular basis of neurodegenerative and cardiac transthyretin diseases, and for developing tafamidis, a drug that slows their progression.
Afiliado al momento del premio
Instituto de Investigación Scripps
La Jolla, Estados Unidos